Maozhang Li

机构：Jinan University, Guangdong Medical College, Huizhou Central People's Hospital, Southern Medical University, Guangzhou Medical University · ORCID：0000-0003-1768-0084

发表论文 13 篇 · 总被引 77 次 · h-index 5

代表论文

• Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway (2023 · Journal of Translational Medicine · 被引 20)
• Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 19)
• KIF4A: A potential biomarker for prediction and prognostic of prostate cancer (2020 · Clinical and investigative medicine · 被引 16)
• CircPDHX promotes prostate cancer cell progression in vitro and tumor growth in vivo via miR-497-5p/ACSL1 axis (2022 · Biochemical and Biophysical Research Communications · 被引 12)
• Functionalized Silver Nanoparticles Enhance Therapeutic Effect of Paclitaxel for Prostate Cancer Therapy by Arresting the Cellular Cycle and Producing ROS (2021 · NANO · 被引 5)
• Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer (2023 · Frontiers in Pharmacology · 被引 2)